Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69.8M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
20M
-
Shares change
-
+537K
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
+$52.3M
-
Number of buys
-
46
-
Number of sells
-
-29
-
Price
-
$62.00
Significant Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q4 2020
88 filings reported holding KYMR - Kymera Therapeutics, Inc. - Common Stock as of Q4 2020.
Kymera Therapeutics, Inc. - Common Stock (KYMR) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20M shares
of 69.8M outstanding shares and own 28.72% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (2.72M shares), BVF INC/IL (2.63M shares), FMR LLC (2.44M shares), BAKER BROS. ADVISORS LP (1.96M shares), Deer IX & Co. Ltd. (1.76M shares), WELLINGTON MANAGEMENT GROUP LLP (1.69M shares), BlackRock Inc. (1.42M shares), Rock Springs Capital Management LP (714K shares), AJU IB Investment Co., Ltd. (704K shares), and VANGUARD GROUP INC (623K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.